AU5906099A - T cell peptides as therapeutics for immune-related disease - Google Patents

T cell peptides as therapeutics for immune-related disease

Info

Publication number
AU5906099A
AU5906099A AU59060/99A AU5906099A AU5906099A AU 5906099 A AU5906099 A AU 5906099A AU 59060/99 A AU59060/99 A AU 59060/99A AU 5906099 A AU5906099 A AU 5906099A AU 5906099 A AU5906099 A AU 5906099A
Authority
AU
Australia
Prior art keywords
therapeutics
immune
related disease
cell peptides
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59060/99A
Inventor
Jingwu Z. Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of AU5906099A publication Critical patent/AU5906099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU59060/99A 1998-09-04 1999-09-01 T cell peptides as therapeutics for immune-related disease Abandoned AU5906099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9910298P 1998-09-04 1998-09-04
US60099102 1998-09-04
PCT/US1999/020009 WO2000014116A1 (en) 1998-09-04 1999-09-01 T cell peptides as therapeutics for immune-related disease

Publications (1)

Publication Number Publication Date
AU5906099A true AU5906099A (en) 2000-03-27

Family

ID=22272725

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59060/99A Abandoned AU5906099A (en) 1998-09-04 1999-09-01 T cell peptides as therapeutics for immune-related disease

Country Status (2)

Country Link
AU (1) AU5906099A (en)
WO (1) WO2000014116A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658926B2 (en) 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
ES2545736T3 (en) 2002-08-08 2015-09-15 Baylor College Of Medicine Isolation and identification of T cells
WO2005087806A2 (en) 2004-02-13 2005-09-22 Boehringer Ingelheim Pharmaceuticals, Inc. Cd38 splice variant and uses thereof
WO2008131599A1 (en) * 2007-04-30 2008-11-06 Maxx Genetech Co., Ltd. T-cell receptor vaccines materials and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614192A (en) * 1989-07-19 1997-03-25 Connective Therapeutics, Inc. T cell receptor peptides as therapeutics for immune-related disease
EP0623025A1 (en) * 1991-12-24 1994-11-09 The Immune Response Corporation Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
AU2701895A (en) * 1994-06-07 1996-01-05 Regents Of The University Of Minnesota Methods for inhibiting antigen specific t cell responses

Also Published As

Publication number Publication date
WO2000014116A1 (en) 2000-03-16

Similar Documents

Publication Publication Date Title
AU4488200A (en) Modified protein matrices
AUPQ223499A0 (en) Fuel cell system
AU2002216399A1 (en) Synovial cell protein
AU2001260606A1 (en) Constituent part for fuel cell
AU3706700A (en) Positively charged membrane
AU2454101A (en) Electrochemical cell system
AU5003600A (en) Charged membrane
AU6045900A (en) Interaction-activated proteins
AU6906200A (en) Fuel cell system
AU6229498A (en) Composition for gene introduction into cell
AU4077099A (en) Cell signaling proteins
AU1618500A (en) Human cell surface receptor proteins
AU4697600A (en) Methods for increasing t cell proliferation
AU5906099A (en) T cell peptides as therapeutics for immune-related disease
AU3478599A (en) Cell cycle regulatory proteins
AU7494200A (en) Proteins associated with cell differentiation
AU3455000A (en) Composition for decomposing protein
AU6634298A (en) Biosensor for cells
AU1881200A (en) Novel proteins
AU2061201A (en) Mammalian dishevelled-associated proteins
AU4855000A (en) Plasma-annealed membrane for protein separation
AU7362398A (en) B cell receptor associated proteins
AU2591199A (en) Cell cycle related proteins
AU4955499A (en) Cell cycle regulation proteins
AU5589399A (en) Method for selecting peptides inhibiting viral surface protein binding to cell surface receptor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase